This prospective observational study compared the clinical outcomes of epinephrine (adrenaline) versus norepinephrine (noradrenaline) as the initial vasoactive agent in pediatric septic shock.

Study Population: 68 children admitted with septic shock to PICUs in Egypt were divided into two groups based on the drug they received.

Initial Severity: The epinephrine group had significantly lower baseline severity scores (PRISM and PRISM III) upon admission compared to the norepinephrine group, suggesting the norepinephrine patients were sicker from the start.

Patients receiving norepinephrine required significantly higher drug doses and greater fluid resuscitation volumes than those on epinephrine.

Predictors of mortality included lower mean BP, prolonged capillary refill time, high CRP/creatinine, metabolic acidosis, hyperkalemia, and high requirements for both fluids and vasoactives.

Despite the norepinephrine group appearing to have a higher initial illness severity, the study suggests that epinephrine was associated with improved clinical outcomes in pediatric septic shock, specifically leading to a lower need for and duration of mechanical ventilation and a shorter PICU stay. The findings warrant further investigation through larger, multicenter randomized trials to definitively guide clinical practice.

Read More